Bill Anderson

Explore the latest news, leadership insights, interviews, strategic initiatives, and corporate developments involving Bill Anderson, Chief Executive Officer (CEO) of Bayer AG. Stay informed on crop protection, seeds, pharmaceuticals, biotechnology, sustainability, digital agriculture, business transformation, and global agribusiness leadership.

William N. (Bill) Anderson has served as the Chief Executive Officer (CEO) and Chairman of the Board of Management of Bayer AG since June 2023. A chemical engineer by training, he holds bachelor’s and master’s degrees in Chemical Engineering and a Master of Science in Management from the Massachusetts Institute of Technology (MIT). Before joining Bayer, Anderson served as CEO of Roche Pharmaceuticals and previously led Genentech as CEO, following senior leadership roles at Biogen, Raychem, and Ethyl Corporation. At Bayer, he is leading a comprehensive transformation focused on strengthening the pharmaceutical pipeline, improving Crop Science profitability, simplifying organizational structures through Dynamic Shared Ownership, accelerating innovation, and advancing sustainability. In 2025, Bayer’s Supervisory Board extended his contract through March 2029, reflecting confidence in the company’s ongoing transformation strategy. This category features executive interviews, strategic announcements, financial results, research and development updates, sustainability programs, mergers and acquisitions, corporate governance, and global agriculture and healthcare developments involving Bill Anderson.

Stay updated on Bill Anderson news, Bayer CEO, Bayer Crop Science, pharmaceutical innovation, crop protection, digital agriculture, sustainability, corporate strategy, and global agribusiness developments.